| MeSH term | MeSH ID | Detail |
|---|---|---|
| Otitis Media | D010033 | 12 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Halperin SA et al. | A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. | 1999 | Pediatrics | pmid:10506267 |
| Lai CC et al. | Analysis of a commercial preparation of erythromycin estolates by tandem mass spectrometry and high performance liquid chromatography/electrospray ionization tandem mass spectrometry using an ion trap mass spectrometer. | 2000 | Rapid Commun. Mass Spectrom. | pmid:10717658 |
| Lavoie JP et al. | Equine proliferative enteropathy: a cause of weight loss, colic, diarrhoea and hypoproteinaemia in foals on three breeding farms in Canada. | 2000 | Equine Vet. J. | pmid:11037264 |
| SanFilippo A | Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases. | 1976 | J. Pediatr. Surg. | pmid:1263054 |
| de Longueville F et al. | Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. | 2003 | Toxicol. Sci. | pmid:12883083 |
| Cachet T et al. | Analysis of erythromycin estolate by liquid chromatography. | 1992 Oct-Dec | J Pharm Biomed Anal | pmid:1298393 |
| Resh W and Stoughton RB | Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones. | 1976 | Arch Dermatol | pmid:134675 |
| HAVENS WP | Cholestatic jaundice in patients treated with erythromycin estolate. | 1962 | JAMA | pmid:13905478 |
| FLEISCHL H | Effect of erythromycin estolate after unsuccessful malaria-penicillin therapy for general paresis. | 1963 | J Am Geriatr Soc | pmid:13945473 |
| REED C and RITCHIE F | Toxic jaundice due to propionyl erythromycin ester lauryl sulphate ("Ilosone"). | 1962 | Med. J. Aust. | pmid:14037477 |
| BROWN AR | TWO CASES OF UNTOWARD REACTION AFTER "ILOSONE". | 1963 | Br Med J | pmid:14067683 |
| GRIFFITH RS and BLACK HR | COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATE. | 1964 | Am. J. Med. Sci. | pmid:14106882 |
| FISCHER HW and HOAK JC | MIMICRY OF ACUTE CHOLECYSTITIS BY ERYTHROMYCIN ESTOLATE REACTIONS. REPORT OF 2 CASES. | 1964 | Am. J. Med. Sci. | pmid:14130320 |
| SOUTH MA et al. | FAILURE OF ERYTHROMYCIN ESTOLATE THERAPY IN IN UTERO SYPHILIS. | 1964 | JAMA | pmid:14197148 |
| Bellomo-Brandão MA et al. | Use of erythromycin for the treatment of severe chronic constipation in children. | 2003 | Braz. J. Med. Biol. Res. | pmid:14502372 |
| Saiz Santos S and Montero López L | [Hepatotoxicity from erythromycin estolate]. | 1992 | Aten Primaria | pmid:1467424 |
| Pari L and Uma A | Protective effect of Sesbania grandiflora against erythromycin estolate-induced hepatotoxicity. | 2003 Sep-Oct | Therapie | pmid:14682193 |
| Park SJ and Kim SH | Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. | 2004 | J Colloid Interface Sci | pmid:14972610 |
| Pari L and Murugan P | Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. | 2004 | Pharmacol. Res. | pmid:14998559 |
| Langley JM et al. | Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. | 2004 | Pediatrics | pmid:15231980 |
| Hoppe JE | Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group. | 1992 | Pediatr. Infect. Dis. J. | pmid:1565532 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2005 | Cochrane Database Syst Rev | pmid:15674946 |
| Hillyer D | Is erythromycin indicated in pregnancy? | 1992 | RN | pmid:1594870 |
| Villa P et al. | Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. | 1992 | Toxicology | pmid:1609428 |
| Murugan P and Pari L | Effect of tetrahydrocurcumin on erythromycin estolate-induced lipid peroxidation in rats. | 2005 | J Basic Clin Physiol Pharmacol | pmid:16187483 |
| Amacher DE et al. | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. | 1991 | Antimicrob. Agents Chemother. | pmid:1656856 |
| Zidek N et al. | Acute hepatotoxicity: a predictive model based on focused illumina microarrays. | 2007 | Toxicol. Sci. | pmid:17522070 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2007 | Cochrane Database Syst Rev | pmid:17636756 |
| Albarellos GA et al. | Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs. | 2008 | J. Vet. Pharmacol. Ther. | pmid:19000270 |
| Ramin U and Wollmann H | [Problems in the determination of water content of lubomycin B capsules]. | 1990 | Pharmazie | pmid:2080216 |
| Morgan RE et al. | Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. | 2010 | Toxicol. Sci. | pmid:20829430 |
| McCormack WM et al. | Hepatotoxicity of erythromycin estolate during pregnancy. | 1977 | Antimicrob. Agents Chemother. | pmid:21610 |
| Raynes Greenow CH et al. | Antibiotics for ureaplasma in the vagina in pregnancy. | 2011 | Cochrane Database Syst Rev | pmid:21901685 |
| Murphy PJ et al. | Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat. | 1975 May-Jun | Drug Metab. Dispos. | pmid:238814 |
| Murphy PJ et al. | Metabolism of propionyl erythromycin lauryl sulfate. II. Fate of the lauryl sulfate moiety in the rat and man. | 1975 May-Jun | Drug Metab. Dispos. | pmid:238815 |
| Morgan RE et al. | A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. | 2013 | Toxicol. Sci. | pmid:23956101 |
| Lu X et al. | Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat. | 2014 | Food Chem. Toxicol. | pmid:24412560 |
| Bocka JJ | Pertussis in an infant. | 1989 Jul-Aug | J Emerg Med | pmid:2689510 |
| Klein MD | Streptococcal pharyngitis in children. | 1989 | Pediatr Emerg Care | pmid:2690022 |
| Cooksley WG and Powell LW | Erythromycin jaundice: diagnosis by an in vitro challenge test. | 1977 | Aust N Z J Med | pmid:269690 |
| Davila JC et al. | Protective effect of flavonoids on drug-induced hepatotoxicity in vitro. | 1989 | Toxicology | pmid:2756528 |
| Stubbs C and Kanfer I | Variability in the absorption and disposition of erythromycin estolate in humans. | 1989 | J Pharm Sci | pmid:2778669 |
| Aleo MD et al. | Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. | 2017 | Chem. Res. Toxicol. | pmid:28437613 |
| Farre M | Erythromycin propionate and estolate. | 1988 | Lancet | pmid:2898648 |
| Gaeta GB et al. | Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. | 1985 | Toxicol. Appl. Pharmacol. | pmid:2992120 |
| Ginsburg CM | A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3080735 |
| Villa P et al. | Effects of a new fluorinated macrolide (P-0501A) and other erythromycins on drug metabolizing enzymes in rat liver. | 1986 | J. Antibiot. | pmid:3084433 |
| Bérubé D et al. | Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers. | 1988 | Antimicrob. Agents Chemother. | pmid:3142349 |
| Laperrière H and Lefebvre J | Persistence of inclusion conjunctivitis after oral erythromycin therapy. | 1988 | CMAJ | pmid:3179892 |